These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14534495)

  • 1. [Prevention of hepatitis C. How to update the pioneer work done by Eugène Jamot?].
    Coton T
    Presse Med; 2003 Sep; 32(29):1349-50. PubMed ID: 14534495
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus. Epidemiology, transmission and prevention.
    van der Poel CL
    Curr Stud Hematol Blood Transfus; 1994; (61):137-63. PubMed ID: 7956327
    [No Abstract]   [Full Text] [Related]  

  • 3. Who: four ways to reduce hepatitis infections in people who inject drugs.
    Cent Eur J Public Health; 2012 Sep; 20(3):207. PubMed ID: 23285521
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C: who is at risk and how do we identify them?
    Goldberg D; Anderson E
    J Viral Hepat; 2004 Sep; 11 Suppl 1():12-8. PubMed ID: 15357858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C prevention and true harm reduction.
    Madden A; Cavalieri W
    Int J Drug Policy; 2007 Oct; 18(5):335-7. PubMed ID: 17854719
    [No Abstract]   [Full Text] [Related]  

  • 6. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modifications of epidemiological characteristics of hepatitis C].
    Roudot-Thoraval F
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B138-43. PubMed ID: 12180281
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C infection among injecting drug users in Scotland: stemming the flow.
    Goldberg D; Taylor A; Hutchinson S; McMenamin J
    Scott Med J; 2000 Oct; 45(5):131-2. PubMed ID: 11130293
    [No Abstract]   [Full Text] [Related]  

  • 9. Routes of transmission of hepatitis C virus.
    Soza A; Riquelme A; Arrese M
    Ann Hepatol; 2010; 9 Suppl():33. PubMed ID: 20713992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 11. Global epidemiology of hepatitis C virus infection.
    Shepard CW; Finelli L; Alter MJ
    Lancet Infect Dis; 2005 Sep; 5(9):558-67. PubMed ID: 16122679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV routes of transmission: what goes around comes around.
    Alter MJ
    Semin Liver Dis; 2011 Nov; 31(4):340-6. PubMed ID: 22189974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of hepatitis C infection: the importance of targeting people who inject drugs.
    Hellard M; Doyle JS; Sacks-Davis R; Thompson AJ; McBryde E
    Hepatology; 2014 Feb; 59(2):366-9. PubMed ID: 23873507
    [No Abstract]   [Full Text] [Related]  

  • 14. Social inclusion and hepatitis C: exploring new possibilities for prevention.
    Treloar C; Valentine K; Fraser S
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):397-404. PubMed ID: 21504397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.
    Goldberg D; Cameron S; McMenamin J
    Commun Dis Public Health; 1998 Jun; 1(2):95-7. PubMed ID: 9644121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: "Syringe exchange and risk of infection with hepatitis B and C viruses".
    Voth EA
    Am J Epidemiol; 2000 Jan; 151(2):207-8. PubMed ID: 10645825
    [No Abstract]   [Full Text] [Related]  

  • 17. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Law MG; Batey RG
    Med J Aust; 2003 Mar; 178(5):197-8. PubMed ID: 12603178
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing hepatitis C virus transmission in Australians who inject drugs.
    Watson KJ
    Med J Aust; 2000 Jan; 172(2):55-6. PubMed ID: 10738472
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Medical Research Award. Hepatitis C virus and eliminating post-transfusion hepatitis.
    Alter HJ; Houghton M
    Nat Med; 2000 Oct; 6(10):1082-6. PubMed ID: 11017126
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus: Prevention, screening, and interpretation of assays.
    Albeldawi M; Ruiz-Rodriguez E; Carey WD
    Cleve Clin J Med; 2010 Sep; 77(9):616-26. PubMed ID: 20810872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.